GPHL appoints Nobel Laureate Randy Schekman as chief scientist
GPHL on March 12th appointed Randy Schekman, the 2013 Nobel Laureate in Physiology or Medicine, as the chief scientist of both the group and its subsidiary Guangzhou General Pharmaceutical Research In
GPHL makes its presence at the Main Media Centre of 2022 Winter Olympics
Recently, the Chinese Medicine Culture Space was unveiled at the Winter Olympic Village for the 2022 Beijing Olympic Winter Games and 2022 Paralympic Winter Games in Beijing.
First Winter Lychee Industry Conference kicks off and GPHL launches new products
The first Winter Lychee Industry Conference organized by the Department of Agriculture and Rural Affairs of Guangdong (DARA) kicked off in Guangzhou on January 5th, 2022.
GPHL's key medical lab gets an Excellent rating
NATCM conducted an interim appraisal of its 141 key laboratories whose 3-year development has been completed. 118 organizations have passed the appraisal, 50 of which received a rating of 'Excellent'.
GPHL's two subsidiaries win Invention and Entrepreneurship Awards
Kouyanqing Granules produced by Baiyunshan can effectively treat recurrent aphthous stomatitis, oral mucositis, oral lichen planus, etc.
Guangzhou Baiyunshan's Development and Marketing Headquarters celebrates topping out
The topping out ceremony for Guangzhou Baiyunshan Biomedical and Healthcare Development and Marketing Headquarters ('Headquarters') was held at the Guangzhou International Bio Island.
GPHL builds Macao's first Chinese medicine pharmaceutical factory in compliance with GMP
The Chinese medicine industry is one of the industries that Macao has focused on in fostering a moderately diversified economy.
GPHL's Ciningji drinks become event supporters for the Greater-Bay Science Forum
On December 11, the Greater-Bay Science Forum 2021 kicked off in Guangzhou. Li Chuyuan, the chairman of GPHL, was invited to the Forum.
Guangzhou Baiyunshan Zhongyi Pharmaceutical awarded ICQCC honor
Xiaomifeng QC Group Team and Xiaonengshou Team from Guangzhou Baiyunshan Zhongyi Pharmaceutical Company Limited attended the case-study presentation and was awarded Par Excellence.
To promote traditional Chinese medicine to the world: GPHL chairman Li Chuyuan
The 2021 Understanding China Conference (Guangzhou) was held from December 1st to 4th in Guangzhou.
GPHL attends 2021 Asia Youth Leaders Forum
GPHL served as presenting partner for this forum and the Group's chairman Li Chuyuan was invited to participate in the opening ceremony and give an address at the welcome banquet.
GPHL signs a cooperation agreement with International Lusophone Markets Business Association
Both sides hope to promote TCM products and culture to Portuguese-speaking countries and explore more opportunities for cooperation.
GPHL has favorable advantages in industrial cooperation between Guangdong and Guangxi: Li Chuyuan
In the future, GPHL will actively deepen its cooperation with Guangxi.
GPHL Q3 2021 business highlights
GPHL has become the first company to enter the Fortune Global 500 with traditional Chinese medicine (TCM) as its major business.
GPHL's listed arm Baiyunshan upgraded to Grade A in the MSCI ESG Ratings
Baiyunshan, a listed subsidiary of Guangzhou Pharmaceutical Holdings Limited (GPHL) was ranked A for its ESG (Environment, Social and Governance) performance.
GPHL invited to 2021 Fortune Global 500 Summit
Nearly 700 entrepreneurs, executives and renowned scholars gathered together to discuss the roles of enterprises and their social responsibilities under the circumstance of COVID-19 pandemic.
